These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 8792695

  • 1. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 2. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 4. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ, Fennerty MB, Joelsson B.
    Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
    [Abstract] [Full Text] [Related]

  • 5. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A.
    N Engl J Med; 1995 Oct 26; 333(17):1106-10. PubMed ID: 7565948
    [Abstract] [Full Text] [Related]

  • 6. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep 26; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 7. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A.
    Am J Gastroenterol; 2007 Jun 26; 102(6):1291-7. PubMed ID: 17319927
    [Abstract] [Full Text] [Related]

  • 8. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug 26; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 9. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun 26; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 10. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
    Robinson M, Decktor DL, Maton PN, Sabesin S, Roufail W, Kogut D, Roberts W, McCullough A, Pardoll P, Saco L.
    Aliment Pharmacol Ther; 1993 Feb 26; 7(1):67-73. PubMed ID: 8439639
    [Abstract] [Full Text] [Related]

  • 11. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug 26; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 12. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S, Italian Lansoprazole Study Group.
    Am J Gastroenterol; 2002 Jun 26; 97(6):1357-64. PubMed ID: 12094850
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP, Haccoun P, Bergmann JF, Arnould B, Hamelin B.
    Ann Gastroenterol Hepatol (Paris); 1993 Jun 26; 29(4):213-8. PubMed ID: 8239492
    [Abstract] [Full Text] [Related]

  • 14. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S, Santucci L, Morelli A.
    Am J Gastroenterol; 1990 Nov 26; 85(11):1458-62. PubMed ID: 2239873
    [Abstract] [Full Text] [Related]

  • 15. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Nov 26; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 16. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
    Zeitoun P, Rampal P, Barbier P, Isal JP, Eriksson S, Carlsson R.
    Gastroenterol Clin Biol; 1989 May 26; 13(5):457-62. PubMed ID: 2666237
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep 26; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 18. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S, Holtmann G.
    Clin Ther; 2010 Apr 26; 32(4):678-90. PubMed ID: 20435237
    [Abstract] [Full Text] [Related]

  • 19. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA, Paoletti V, Leite L, Castell DO.
    Am J Gastroenterol; 1996 Oct 26; 91(10):2110-3. PubMed ID: 8855731
    [Abstract] [Full Text] [Related]

  • 20. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ, Mills JG, Goodwin C, Wood JR.
    Eur J Gastroenterol Hepatol; 1995 Sep 26; 7(9):817-22. PubMed ID: 8574711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.